Christiane Iserman

Christiane Iserman is a senior scientist at Dewpoint Therapeutics. Christiane received their PhD from the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden, Germany, where they studied the phase behavior of prion-like RNA-binding proteins in vitro and in vivo. Her research has been published in several peer-reviewed journals, and they have presented their work at international conferences.

Dr. Christiane Iserman has a Doctorate in Natural Sciences from the Technische Universität Dresden, a Biology degree from the University of Düsseldorf, and a General Biology degree from Michigan State University.

Christiane Iserman reports to Isaac Klein, Chief Scientific Officer. Christiane Iserman works with Violeta Yu - Head of Neuromuscular & Rare Disease Biology, Ben Levin - Senior Scientist, and Eric Riguet - Director, Medicinal Chemistry.